Chemical activators of FAM14B function through a variety of cellular mechanisms that result in the increased activity of this specific protein. Some of these activators work by increasing the levels of intracellular cyclic AMP (cAMP), a critical secondary messenger in numerous signaling pathways. By activating adenylyl cyclase or inhibiting phosphodiesterases, the levels of cAMP within the cell rise, leading to the activation of protein kinase A (PKA). PKA then phosphorylates target proteins, which may include FAM14B, resulting in its enhanced activity. Furthermore, certain activators that bind to beta-adrenergic receptors can also stimulate the production of cAMP, thereby indirectly leading to the activation of FAM14B through this well-characterized signaling cascade. Similarly, adrenergic receptor agonists can increase intracellular cAMP levels, potentially leading to the activation of FAM14B through the same cAMP-dependent mechanisms.
Other activators operate by modulating intracellular calcium concentrations, which is another pivotal factor in the regulation of various proteins and signaling pathways. Calcium ionophores, for example, directly increase intracellular calcium levels, which can activate calcium-dependent signaling pathways potentially involving FAM14B. The elevation of intracellular calcium can activate a range of calcium-dependent kinases, phosphatases, and other proteins that could, in turn, increase the activity of FAM14B. Additionally, activators such as protein kinase C (PKC) agonists can initiate signaling cascades that lead to the phosphorylation of specific proteins which may be required for the full activation of FAM14B.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP breakdown, potentially increasing FAM14B activity through elevated cAMP signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C (PKC) that could enhance FAM14B activity by PKC-mediated signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases intracellular calcium levels, possibly promoting FAM14B activity through calcium-dependent mechanisms. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that can activate FAM14B by elevating intracellular calcium and activating calcium-dependent signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that can increase cAMP levels, potentially leading to enhanced FAM14B activity via cAMP-mediated signaling. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Adrenergic receptor agonist that elevates cAMP levels, which may lead to increased FAM14B activity through cAMP-dependent pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase-4 inhibitor that raises cAMP levels, potentially promoting FAM14B activity through cAMP-dependent protein kinase A (PKA). | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that can activate PKA, potentially leading to enhanced FAM14B activity through cAMP-dependent pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Phosphodiesterase inhibitor that may increase cAMP and cGMP levels, potentially enhancing FAM14B activity via these signaling pathways. | ||||||